Total Payments
$32,728
2024 Payments
$6,411
Companies
38
Transactions
420
Medicare Patients
2,888
Medicare Billing
$488,229
Payment Breakdown by Category
Other$27,162 (83.0%)
Food & Beverage$5,317 (16.2%)
Education$249.93 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,162 | 49 | 83.0% |
| Food and Beverage | $5,317 | 368 | 16.2% |
| Education | $249.93 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $14,608 | 36 | $0 (2023) |
| ABBVIE INC. | $13,729 | 94 | $0 (2024) |
| Janssen Biotech, Inc. | $1,153 | 96 | $0 (2024) |
| PFIZER INC. | $532.39 | 36 | $0 (2023) |
| Genentech USA, Inc. | $335.80 | 20 | $0 (2022) |
| Celgene Corporation | $274.75 | 18 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $217.87 | 11 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $193.19 | 10 | $0 (2022) |
| Amgen Inc. | $182.22 | 11 | $0 (2022) |
| LEO Pharma Inc. | $168.52 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,411 | 16 | ABBVIE INC. ($6,290) |
| 2023 | $7,467 | 51 | AbbVie Inc. ($6,362) |
| 2022 | $8,017 | 97 | Allergan, Inc. ($6,867) |
| 2021 | $7,650 | 50 | Allergan, Inc. ($6,992) |
| 2020 | $225.58 | 13 | AbbVie Inc. ($59.92) |
| 2019 | $868.71 | 54 | AbbVie, Inc. ($188.96) |
| 2018 | $1,117 | 78 | AbbVie, Inc. ($238.60) |
| 2017 | $971.69 | 61 | AbbVie, Inc. ($181.73) |
All Payment Transactions
420 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $567.75 | General |
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $620.75 | General |
| 10/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $549.25 | General |
| 09/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $208.75 | General |
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $323.45 | General |
| 07/02/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $585.00 | General |
| 06/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $492.35 | General |
| 05/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $655.00 | General |
| 04/11/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $738.40 | General |
| 03/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $252.50 | General |
| 02/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $527.50 | General |
| 01/05/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $757.10 | General |
| 01/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 01/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.56 | General |
| Category: Dermatology | ||||||
| 12/22/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Immunology | ||||||
| 12/18/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/05/2023 | AbbVie Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $989.90 | General |
| 12/01/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Immunology | ||||||
| 11/21/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Immunology | ||||||
| 11/10/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Immunology | ||||||
| 11/09/2023 | AbbVie Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $411.50 | General |
| 10/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Immunology | ||||||
| 10/06/2023 | AbbVie Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $689.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 14 | 868 | 1,436 | $403,922 | $138,390 |
| 2021 | 15 | 1,078 | 5,275 | $496,336 | $174,119 |
| 2020 | 15 | 942 | 5,551 | $508,269 | $175,719 |
Total Patients
2,888
Total Services
12,262
Medicare Billing
$488,229
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 107 | 136 | $163,200 | $60,884 | 37.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 39 | 52 | $37,076 | $15,603 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 247 | $31,122 | $13,864 | 44.5% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 18 | 19 | $20,900 | $8,657 | 41.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 38 | 44 | $44,924 | $7,874 | 17.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 90 | 106 | $19,398 | $6,233 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 121 | 175 | $14,175 | $6,030 | 42.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 24 | 24 | $18,000 | $5,462 | 30.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 96 | 140 | $17,500 | $4,787 | 27.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 40 | 44 | $8,096 | $3,066 | 37.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 11 | 11 | $5,720 | $1,855 | 32.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 64 | 382 | $16,044 | $1,818 | 11.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 32 | 45 | $4,500 | $1,676 | 37.2% |
| 69100 | Biopsy of ear | Office | 2022 | 11 | 11 | $3,267 | $581.13 | 17.8% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 131 | 166 | $199,200 | $75,993 | 38.1% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2021 | 43 | 57 | $40,641 | $17,560 | 43.2% |
| 17313 | Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | Office | 2021 | 25 | 29 | $31,900 | $13,851 | 43.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 227 | 328 | $26,568 | $10,838 | 40.8% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 53 | 54 | $55,134 | $10,528 | 19.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 155 | 172 | $21,672 | $10,445 | 48.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 111 | 139 | $25,437 | $8,682 | 34.1% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2021 | 22 | 27 | $20,250 | $5,428 | 26.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 117 | 155 | $19,375 | $5,061 | 26.1% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2021 | 12 | 3,600 | $10,800 | $4,467 | 41.4% |
| 13101 | Repair of wound (2.6 to 7.5 centimeters) of trunk | Office | 2021 | 14 | 16 | $11,088 | $3,528 | 31.8% |
About Dr. John Buker, M.D
Dr. John Buker, M.D is a MOHS-Micrographic Surgery healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457355174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Buker, M.D has received a total of $32,728 in payments from pharmaceutical and medical device companies, with $6,411 received in 2024. These payments were reported across 420 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,162).
As a Medicare-enrolled provider, Buker has provided services to 2,888 Medicare beneficiaries, totaling 12,262 services with total Medicare billing of $488,229. Data is available for 3 years (2020–2022), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Lexington, KY
- Active Since 06/10/2005
- Last Updated 07/17/2012
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457355174
Products in Payments
- TREMFYA (Drug) $743.70
- Humira (Biological) $561.99
- EUCRISA (Drug) $491.06
- Erivedge (Biological) $308.53
- SKYRIZI (Biological) $235.33
- Tremfya (Drug) $218.86
- HUMIRA (Biological) $184.47
- COSENTYX (Biological) $174.53
- DUPIXENT (Biological) $150.62
- STELARA (Biological) $117.46
- ILUMYA (Biological) $94.03
- Otezla (Drug) $91.98
- ENSTILAR (Drug) $90.76
- DORYX (Drug) $85.83
- ELZONRIS (Drug) $83.59
- Sitavig (Drug) $82.26
- Enbrel (Biological) $76.22
- TALTZ (Drug) $75.37
- REMICADE (Biological) $72.58
- LIBTAYO (Biological) $65.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.